These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 31779058)

  • 21. Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.
    Kang S; Lee YH; Lee JE
    Yonsei Med J; 2017 May; 58(3):479-488. PubMed ID: 28332351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New animal models of Alzheimer's disease that display insulin desensitization in the brain.
    Gao C; Liu Y; Li L; Hölscher C
    Rev Neurosci; 2013; 24(6):607-15. PubMed ID: 24259244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pancreas-brain axis: insight into disrupted mechanisms associating type 2 diabetes and Alzheimer's disease.
    Desai GS; Zheng C; Geetha T; Mathews ST; White BD; Huggins KW; Zizza CA; Broderick TL; Babu JR
    J Alzheimers Dis; 2014; 42(2):347-56. PubMed ID: 24858405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
    FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
    Chung JY; Kim HS; Song J
    Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathological changes induced by amyloid-β in Alzheimer's disease].
    Takata K; Kitamura Y; Taniguchi T
    Yakugaku Zasshi; 2011 Jan; 131(1):3-11. PubMed ID: 21212607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms.
    Guerrero-Berroa E; Schmeidler J; Beeri MS
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1961-6. PubMed ID: 24529419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexisting pathologies in the brain: influence of vascular disease and Parkinson's disease on Alzheimer's pathology in the hippocampus.
    Smith MZ; Nagy Z; Barnetson L; King EM; Esiri MM
    Acta Neuropathol; 2000 Jul; 100(1):87-94. PubMed ID: 10912925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Islet amyloid polypeptide: Another key molecule in Alzheimer's pathogenesis?
    Zhang Y; Song W
    Prog Neurobiol; 2017 Jun; 153():100-120. PubMed ID: 28274676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
    Stanley M; Macauley SL; Holtzman DM
    J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
    Cho JE; Kim JR
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease.
    Batarseh YS; Kaddoumi A
    J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.